Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05312437 · ClinicalTrials.gov registry record · NA

Clinical Decision Support to Prevent Suicide

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
596
Enrollment target

NCT05312437 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 596 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05312437, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
596 participants
Enrollment target

Study Summary

Suicide kills 132 Americans every day. The first step of suicide prevention is risk identification and prognostication. Researchers like this study team have developed and validated predictive models that use routinely collected Electronic Health Record (EHR) data like past diagnoses and medications to predict future suicide attempt risk. The study team's model based in machine learning is known as the Vanderbilt Suicide Attempt and Ideation Likelihood (VSAIL). VSAIL has been validated prospectively and externally to predict suicide attempt risk with a number needed to screen (NNS) of 271 for suicide attempt and 23 for suicidal ideation. NNS is the number of people who need to receive a test result to prevent one outcome - lower NNS is better. This study will evaluate the effectiveness of a Clinical Decision Support System called Vanderbilt Safecourse using VSAIL to prompt a novel Best Practice Advisory (BPA) to prompt face-to-face screening with a validated suicide screening instrument like the Columbia Suicide Severity Rating Scale (CSSRS).

Interventions

  • OTHER Interruptive Alert, CDS
  • OTHER Passive Prompt, CDS

Trial Details

FieldValue
Enrollment Target 596 participants
Start Date 2022-08-16
Est. Completion 2023-02-16
Phase NA

What the Registry Record Tells You About NCT05312437

The ClinicalTrials.gov registry entry for NCT05312437 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 596 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Interruptive Alert, CDS is the first listed.

NCT05312437 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05312437 about?

NCT05312437 is a clinical study titled "Clinical Decision Support to Prevent Suicide". Suicide kills 132 Americans every day. The first step of suicide prevention is risk identification and prognostication. Researchers like this study team have developed and validated predictive models that use routinely collected Electronic Health Record (EHR) data like past diagnoses and medications...

What is the current status of trial NCT05312437?

This trial is currently completed. It is a NA study. The enrollment target is 596 participants. The study started on 2022-08-16. Estimated completion is 2023-02-16.

What interventions are being tested in trial NCT05312437?

The interventions under investigation include: Interruptive Alert, CDS (OTHER), Passive Prompt, CDS (OTHER).

Who is sponsoring clinical trial NCT05312437?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.